Aristotle Capital Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aristotle Capital Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$60,031,796
+1.4%
589,356
+0.4%
0.13%
+7.5%
Q2 2023$59,210,104
+12.7%
586,762
+2.7%
0.12%
+9.1%
Q1 2023$52,543,717
+2.8%
571,127
+1.4%
0.11%
+1.9%
Q4 2022$51,109,197
+14.8%
563,373
-3.8%
0.11%
+9.1%
Q3 2022$44,532,000
-11.5%
585,867
-1.5%
0.10%
-6.6%
Q2 2022$50,301,000
-2.1%
595,072
+1.6%
0.11%
+12.8%
Q1 2022$51,377,000
+4.5%
585,489
+4.1%
0.09%
+13.3%
Q4 2021$49,176,000
-92.6%
562,209
-93.1%
0.08%
-93.4%
Q3 2021$664,682,000
-9.7%
8,127,686
+0.8%
1.26%
-10.7%
Q2 2021$735,951,000
+8.9%
8,066,097
+2.0%
1.41%
+1.9%
Q1 2021$676,032,000
+0.6%
7,908,653
+11.1%
1.38%
-17.3%
Q4 2020$672,159,000
+14.4%
7,118,064
+5.3%
1.67%
-6.0%
Q3 2020$587,806,000
+2.5%
6,759,493
+2.9%
1.78%
-7.9%
Q2 2020$573,704,000
+18.3%
6,568,632
+11.7%
1.93%
-5.8%
Q1 2020$485,031,000
-11.5%
5,882,729
+1.6%
2.05%
+13.6%
Q4 2019$548,082,000
+79.7%
5,788,168
+64.9%
1.80%
+11.4%
Q3 2019$305,050,000
-1.6%
3,510,362
+3.3%
1.62%
-6.6%
Q2 2019$310,151,000
-7.8%
3,396,680
-3.0%
1.73%
-13.4%
Q1 2019$336,498,000
+27.8%
3,500,084
+14.1%
2.00%
+12.5%
Q4 2018$263,287,000
-16.5%
3,068,255
-16.2%
1.78%
-3.3%
Q3 2018$315,369,000
+13.3%
3,660,270
-0.6%
1.84%
+7.2%
Q2 2018$278,292,000
+1.2%
3,684,040
+8.4%
1.71%
-7.2%
Q1 2018$274,861,000
+2.5%
3,399,641
+6.4%
1.85%
-0.8%
Q4 2017$268,263,000
+4.9%
3,195,134
+7.2%
1.86%
-6.4%
Q3 2017$255,795,000
+2.6%
2,979,550
-0.3%
1.99%
-4.6%
Q2 2017$249,427,000
+16.9%
2,988,222
+4.0%
2.08%
+7.2%
Q1 2017$213,419,000
+6.1%
2,873,554
+4.1%
1.94%
-1.3%
Q4 2016$201,140,000
-6.2%
2,761,401
+1.7%
1.97%
-11.7%
Q3 2016$214,484,000
-5.0%
2,716,368
-0.8%
2.23%
-9.0%
Q2 2016$225,845,000
+50.3%
2,737,194
+31.9%
2.45%
+40.4%
Q1 2016$150,301,000
-7.4%
2,074,844
+9.9%
1.74%
-11.0%
Q4 2015$162,384,000
-2.6%
1,887,310
+4.1%
1.96%
-5.9%
Q3 2015$166,643,000
-6.0%
1,812,915
+0.5%
2.08%
-0.3%
Q2 2015$177,371,000
+1.0%
1,803,652
+1.3%
2.09%
-4.3%
Q1 2015$175,581,000
+955.9%
1,780,555
+892.2%
2.18%
+1900.9%
Q4 2014$16,629,000
+23.9%
179,464
+25.9%
0.11%
-38.4%
Q3 2014$13,419,000
+13.7%
142,557
+9.4%
0.18%
+12.7%
Q2 2014$11,797,000
-31.6%
130,313
-35.8%
0.16%
-37.2%
Q1 2014$17,250,000
+71.8%
202,897
+62.4%
0.25%
+56.2%
Q4 2013$10,043,000
+128.8%
124,940
+118.4%
0.16%
+81.8%
Q3 2013$4,389,000
+107.2%
57,219
+91.0%
0.09%
+51.7%
Q2 2013$2,118,00029,9530.06%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders